685 results on '"Kitchener, Henry"'
Search Results
2. The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome
3. Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial
4. Optimising future cervical screening strategies
5. Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials
6. Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiative
7. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial
8. 16/18 genotyping in triage of persistent human papillomavirus infections with negative cytology in the English cervical screening pilot
9. 3408: Ten-year results of the PORTEC-3 trial: adjuvant therapy for women with high-risk endometrial cancer
10. Ki-67 in endometrial cancer: scoring optimization and prognostic relevance for window studies
11. PROgesterone Therapy for Endometrial Cancer Prevention in Obese Women (PROTEC) Trial: A Feasibility Study
12. Working together to shape the endometrial cancer research agenda: The top ten unanswered research questions
13. Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study
14. Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial
15. Premalignant disease in the genital tract in pregnancy
16. Table S1 from PROgesterone Therapy for Endometrial Cancer Prevention in Obese Women (PROTEC) Trial: A Feasibility Study
17. Supplementary Materials from Body Mass Index, Hormone Replacement Therapy, and Endometrial Cancer Risk: A Meta-Analysis
18. Supplementary table 1 from PRE-surgical Metformin In Uterine Malignancy (PREMIUM): a Multi-Center, Randomized Double-Blind, Placebo-Controlled Phase III Trial
19. Supplementary Data from PRE-surgical Metformin In Uterine Malignancy (PREMIUM): a Multi-Center, Randomized Double-Blind, Placebo-Controlled Phase III Trial
20. Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
21. Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative
22. Lymphadenectomy in Endometrial Cancer: The Controversy Rages Unabated
23. Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study
24. Ovarian cancer
25. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
26. Urine testing for HPV
27. Risk of Newly Detected Infections and Cervical Abnormalities in Women Seropositive for Naturally Acquired Human Papillomavirus Type 16/18 Antibodies: Analysis of the Control Arm of PATRICIA
28. Human papillomavirus and cervical cancer
29. Development of a pre-notification leaflet to encourage uptake of cervical screening at first invitation: a qualitative study
30. Developing role of HPV in cervical cancer prevention
31. Cervical Cancer: A Global Health Crisis
32. Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial
33. Therapy of Human Papillomavirus-Related Disease
34. Cost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neoplasia in England: economic analysis from NHS Sentinel Sites Study
35. Body mass index does not influence post-treatment survival in early stage endometrial cancer: Results from the MRC ASTEC trial
36. Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
37. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
38. Extension of cervical screening intervals with primary human papillomavirus testing: observational study of English screening pilot data
39. Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial:Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation Therapy
40. Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation Therapy
41. Uptake of First Two Doses of Human Papillomavirus Vaccine by Adolescent Schoolgirls in Manchester: Prospective Cohort Study
42. A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: Extended follow up in the ARTISTIC trial
43. Automation-assisted versus manual reading of cervical cytology (MAVARIC): a randomised controlled trial
44. Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation Therapy
45. Effect Of Testing For Human Papillomavirus As A Triage During Screening For Cervical Cancer: Observational Before And After Study
46. The role of human papillomavirus in the genesis of cervical cancer
47. A prospective study of anal cancer screening in HIV-positive and negative MSM
48. Ovary and fallopian tube
49. HPV testing alone is not as safe as cytology and selective HPV testing: AGAINST: There is powerful evidence for primary cervical screening
50. Mortality Associated with Oral Contraceptive Use
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.